AGIOS PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 88 SIDNEY STREET, CAMBRIDGE, MA 02139
官方登記資料
0位追蹤者
2008成立於
關於 AGIOS PHARMACEUTICALS, INC.
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Source: Wikipedia
產業Pharmaceutical Preparations
總部88 SIDNEY STREET, CAMBRIDGE, MA 02139
成立時間2008
法律形式C Corporation
狀態營運中
專利515 項專利
BCAT2 INHIBITORSUS20260159512A1 · 2026
USE OF THE PYRUVATE KINASE ACTIVATOR TEBAPIVAT IN THE TREATMENT OF RENAL FIBROSIS AND OTHER RENAL DISEASESWO2026096368A1 · 2026
關鍵數據
法律資訊
| 法定名稱 | AGIOS PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1439222在 SEC EDGAR 上查看 ↗ |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 88 SIDNEY STREET, CAMBRIDGE, MA 02139 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日